Definition of Solanezumab. Meaning of Solanezumab. Synonyms of Solanezumab

Here you will find one or more explanations in English for the word Solanezumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Solanezumab and, of course, Solanezumab synonyms and on the right images related to the word Solanezumab.

Definition of Solanezumab

No result for Solanezumab. Showing similar results...

Meaning of Solanezumab from wikipedia

- Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease...
- III clinical trial. Solanezumab, an anti-Aβ mAb, targets the N-terminus of Aβ. In Phase I and Phase II of clinical trials, Solanezumab treatment resulted...
- the USP Dictionary or in the WHO INN stembook. If the name of the drug solanezumab were to be broken down, it would be divided into two parts like this:...
- fluid. In a double-blind trial of the humanised monoclonal antibody solanezumab (n = 2042), sixteen patients (11 taking the drug, 5 taking a placebo)...
- amyloid-modifying therapies. Human monoclonal antibodies such as aducanumab, solanezumab, and bapineuzumab have been ****ociated with these neuroimaging changes...
- included aducanumab, bapineuzumab, crenezumab, gantenerumab, lecanemab, and solanezumab. Imaging compounds, notably Pittsburgh compound B, (6-OH-BTA-1, a thioflavin)...
- treatment of Alzheimer's disease. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid-β peptides. In June 2022...
- rheumatoid arthritis Sofituzumab vedotin mab humanized CA-125 ovarian cancer Solanezumab mab humanized β-amyloid Alzheimer's disease Solitomab BiTE mouse EpCAM...
- The center has coordinated important clinical trials on AD drugs like solanezumab. As of 2008, 75 research sites in the United States and Canada were part...
- just three months after Eli Lilly & Co. announced its own setback with solanezumab. In September 2014 AstraZeneca and Eli Lilly and Company announced an...